alexa In Vitro Synergism Testing of Three Antimicrobial Agents against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis byCheckerboard Method
ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

In Vitro Synergism Testing of Three Antimicrobial Agents against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis byCheckerboard Method

Liping Yan, Linlin Zhang, Hua Yang and Heping Xiao*
Department of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, China
Corresponding Author : Heping Xiao
Department of Tuberculosis
Shanghai Pulmonary Hospital
Tongji University School of Medicine
507 Zhengmin Rd.,Shanghai 200433
People’s Republic of China
Tel: 86-21-65115006
Fax: 86-21-65111298
E-mail: [email protected]
Received December 17, 2014; Accepted January 06, 2015; Published January 15, 2015
Citation: Yan L, Zhang L, Yang H, Xiao H (2015) In Vitro Synergism Testing Of Three Antimicrobial Agents against Multidrug-Resistant and Extensively Drug- Resistant Mycobacterium Tuberculosis by Checkerboard Method. J Mol Pharm Org Process Res 2:123. doi: 10.4172/2329-9053.1000123
Copyright: © 2015 Yan L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google
 

Abstract

Objective: In view of the national key project for infectious diseases “the retreatment research of tuberculosis”, we determined the in vitro anti-mycobacterial activity of four drugs in the treatment, pasiniazid (Pa), moxifloxacin (Mfx), Rifabutin (Rfb) and rifapentini (Rft) in combination to multidrug-resistant and extensively drug-resistant mycobacterium tuberculosis. Method: Three-dimensional checkerboard in Middlebrook 7H9 broth microdilutions was used to detect the fractional inhibitory concentration index (FICI) of anti-tuberculosis drug combination (MfxPa, MfxPaRfb and MfxPaRft) to twenty clinical isolates of Mycobacterium tuberculosis, including ten multidrug-resistant isolates and ten extensively drug-resistant isolates. The test results were interpreted by calculating the FICI to judge the in vitro synergy, with FICI < 0. 5 and FICI < 0.75 as the basis of two drugs and three drugs have synergy. Results: The FICI range of MfxPa combination for multidrug-resistant isolates and ten extensively drug-resistant isolates was 0.28-1, only three isolates <0.5, showed synergistic effect. The FICI range of MfxPaRfb combination for ten isolates of multidrug-resistant isolates was from 0.31 to 1.25, two isolates <0.75, showed synergistic effect and for ten isolates of extensively drug-resistant isolates was from 0.53to 1.25, five isolates <0.75, showed synergistic effect. The FICI range of MfxPaRft combination for ten isolates of multidrug-resistant isolates was from 0.16to 0.655, all showed synergistic effect and for ten isolates of extensively drug-resistant isolates was from 0.34 to 1.68, five isolates<0.75, showed synergistic effect. Conclusion: The synergism of MfxPa combination was poor. When a third agent (Rfb or Rft) was added to the combination, the synergistic effect was better. The MfxPaRft combination showed better synergism than MfxPaRfb combination.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords